Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07349810 · ClinicalTrials.gov registry record · Phase 4
Post Operative Infusion Pump Pain Study
A Phase 4 study of Post Operative Pain, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT07349810 is a Phase 4 study of Post Operative Pain that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 80 participants, below the 235-participant average among 56 other Post Operative Pain trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07349810, a Phase 4 study of Post Operative Pain, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will be a pragmatic, prospective cluster randomized trial, where clusters will formed based on sequential 2 week time increments across the study recruitment period.. Patients 18 years or older undergoing ACL reconstruction, open shoulder labrum or rotator cuff surgery, arthroscopic rotator cuff repair, proximal or distal patellar realignment surgery, open knee arthrotomy cases (i.e. inside out meniscus repair, osteochondral allograft transplantation (OCA), meniscal allograft transplantation (MAT)) at University Center for Ambulatory Surgery, LLC (UOA) will be reviewed for eligibility. Once identified, potential study subjects will be asked whether they are interested in participating in the project. If the patient agrees, the subject will be given the informed consent to read and sign. Objectives: The primary objective is to compare the effectiveness of postoperative infusion pain pump versus preoperative nerve block in reducing visual analog pain scores/numerical pain rating scale (VAS/NPRS) in the postoperative period. The second objective is to evaluate the requirement of narcotic and non-narcotic analgesic medications between the two groups. Hypotheses: Use of continuous infusion pain pump or single shot peripheral block will result in similar post-operative pain control after outpatient sports medicine surgical cases.
Conditions Studied
Interventions
- DRUG Bupivacaine 0.5% Injectable Solution
- DRUG Ropivacaine 0.2% Injectable Solution
- DRUG 1.3% liposomal bupivacaine (Exparel)
- DEVICE ambIT Infusion Pump
Study Locations (1)
New Jersey
- University Center for Ambulatory Surgery - Somerset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2026-01-01 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07349810
The ClinicalTrials.gov registry entry for NCT07349810 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 235-participant average among 56 other Post Operative Pain trials with a reported enrollment target (66% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post Operative Pain appearing as the primary indexed condition, and to 4 interventions - of which Bupivacaine 0.5% Injectable Solution is the first listed.
NCT07349810 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT07349810 about?
NCT07349810 is a clinical study titled "Post Operative Infusion Pump Pain Study". This study will be a pragmatic, prospective cluster randomized trial, where clusters will formed based on sequential 2 week time increments across the study recruitment period.. Patients 18 years or older undergoing ACL reconstruction, open shoulder labrum or rotator cuff surgery, arthroscopic rotat...
What is the current status of trial NCT07349810?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2026-01-01. Estimated completion is 2026-12-31.
What conditions does trial NCT07349810 study?
This clinical trial studies the following conditions: Post Operative Pain.
What interventions are being tested in trial NCT07349810?
The interventions under investigation include: Bupivacaine 0.5% Injectable Solution (DRUG), Ropivacaine 0.2% Injectable Solution (DRUG), 1.3% liposomal bupivacaine (Exparel) (DRUG), ambIT Infusion Pump (DEVICE).
Who is sponsoring clinical trial NCT07349810?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07349810 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Operative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi
RECRUITING · Phase 4
-
Preoperative Acetazolamide
RECRUITING · Phase 4
-
Methadone to Reduce Chronic Opioid Use After Major Spine Surgery: The MEND Pilot Feasibility Study
RECRUITING · Phase 4
-
Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties
RECRUITING · Phase 4
-
ZYNRELEF for Pain Management in Total Knee Arthroplasty
RECRUITING · Phase 4
-
Opioid Use After Laparoscopic Salpingectomy
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.